These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29721583)

  • 21. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of hyper osmotic resistant CHO host cells for enhanced antibody production.
    Kamachi Y; Omasa T
    J Biosci Bioeng; 2018 Apr; 125(4):470-478. PubMed ID: 29233458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting the quality of therapeutic proteins in recombinant Chinese hamster ovary cell culture.
    Ha TK; Kim D; Kim CL; Grav LM; Lee GM
    Biotechnol Adv; 2022; 54():107831. PubMed ID: 34480988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production.
    Dizon-Maspat J; Bourret J; D'Agostini A; Li F
    Biotechnol Bioeng; 2012 Apr; 109(4):962-70. PubMed ID: 22094920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An automated high inoculation density fed-batch bioreactor, enabled through N-1 perfusion, accommodates clonal diversity and doubles titers.
    Olin M; Wolnick N; Crittenden H; Quach A; Russell B; Hendrick S; Armstrong J; Webster T; Hadley B; Dickson M; Hodgkins J; Busa K; Connolly R; Downey B
    Biotechnol Prog; 2024; 40(2):e3410. PubMed ID: 38013663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orbitally Shaken Single-Use Bioreactor for Animal Cell Cultivation: Fed-Batch and Perfusion Mode.
    Bürgin T; Coronel J; Hagens G; Keebler MV; Genzel Y; Reichl U; Anderlei T
    Methods Mol Biol; 2020; 2095():105-123. PubMed ID: 31858465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells.
    Combs RG; Yu E; Roe S; Piatchek MB; Jones HL; Mott J; Kennard ML; Goosney DL; Monteith D
    Biotechnol Prog; 2011; 27(1):201-8. PubMed ID: 21312367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catechins prevent monoclonal antibody fragmentation during production via fed-batch culture of Chinese hamster ovary cells.
    Yamaguchi T; Ishikawa H; Fukuda M; Sugita Y; Furuie M; Nagano R; Suzawa T; Yamamoto K; Wakamatsu K
    Biotechnol Prog; 2024; 40(3):e3447. PubMed ID: 38415979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment.
    Ding C; Ardeshna H; Gillespie C; Ierapetritou M
    Biotechnol Bioeng; 2022 Dec; 119(12):3567-3583. PubMed ID: 36109341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the influence of physiologically relevant hydrostatic pressure on CHO cell batch culture.
    Shang M; Kwon T; Hamel JP; Lim CT; Khoo BL; Han J
    Sci Rep; 2021 Jan; 11(1):162. PubMed ID: 33420324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production.
    Mahé A; Martiné A; Fagète S; Girod PA
    Bioprocess Biosyst Eng; 2022 Feb; 45(2):297-307. PubMed ID: 34750672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting cell death pathways in fed-batch bioreactors.
    Mentlak DA; Raven J; Moses T; Massie F; Barber N; Hoare R; Burton G; Young A; Pybus LP; Rosser S; White RJ; Ungar D; Bryant NJ
    Biotechnol J; 2024 Jan; 19(1):e2300257. PubMed ID: 38038229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications.
    MacDonald MA; Nöbel M; Roche Recinos D; Martínez VS; Schulz BL; Howard CB; Baker K; Shave E; Lee YY; Marcellin E; Mahler S; Nielsen LK; Munro T
    Crit Rev Biotechnol; 2022 Nov; 42(7):1099-1115. PubMed ID: 34844499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Super7 passaging method to improve Chinese hamster ovary cell fed-batch performance.
    Moran MJ; Chen J; Piret JM; Balcarcel RR
    Biotechnol Bioeng; 2024 Oct; 121(10):3068-3075. PubMed ID: 38659198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bench-Scale Stirred-Tank Bioreactor for Recombinant Protein Production in Chinese Hamster Ovary (CHO) Cells in Suspension.
    Monteil D; Kuan J
    Methods Mol Biol; 2024; 2810():235-247. PubMed ID: 38926283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilizing targeted integration CHO pools to potentially accelerate the GMP manufacturing of monoclonal and bispecific antibodies.
    Barnard GC; Zhou M; Shen A; Yuk IH; Laird MW
    Biotechnol Prog; 2024; 40(1):e3399. PubMed ID: 37874920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemometrics and in-line near infrared spectroscopic monitoring of a biopharmaceutical Chinese hamster ovary cell culture: prediction of multiple cultivation variables.
    Clavaud M; Roggo Y; Von Daeniken R; Liebler A; Schwabe JO
    Talanta; 2013 Jul; 111():28-38. PubMed ID: 23622522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioreactor scale up and protein product quality characterization of piggyBac transposon derived CHO pools.
    Rajendra Y; Balasubramanian S; Peery RB; Swartling JR; McCracken NA; Norris DL; Frye CC; Barnard GC
    Biotechnol Prog; 2017 Mar; 33(2):534-540. PubMed ID: 28188692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events.
    Fratz-Berilla EJ; Angart P; Graham RJ; Powers DN; Mohammad A; Kohnhorst C; Faison T; Velugula-Yellela SR; Trunfio N; Agarabi C
    Biotechnol Bioeng; 2020 Sep; 117(9):2802-2815. PubMed ID: 32436993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.